Hematological Malignancies and Cellular Therapy
Innovators in Blood and Marrow Stem Cell Transplantation
The Duke Division of Hematological Malignancies and Cellular Therapy is internationally recognized for its novel approaches to treating leukemia, lymphoma, and myeloma through bone marrow and stem cell transplantation. We also treat novel indications such as autoimmune disease and hemoglobinopathies.
The Division of Hematological Malignancies and Cellular Therapy pioneers the very latest and most promising approaches to bone marrow and stem cell transplantation.
This work provides patients early access to these treatments, which is of special importance to those with refractory or recurrent malignancies.
Duke's clinicians and scientists work in close proximity, bringing patients the benefit of a true "bench-to-bedside" approach to care that offers promising new therapies quickly to those who need them most. The result of these efforts is a program unsurpassed in our service region and unequaled in most parts of the country or the world.
Train with us
The Hematology-Oncology Fellowship program provides clinical and laboratory training in hematology, medical oncology, and bone marrow transplantation.
At the Duke Adult Bone Marrow Transplant Clinic, our physicians, nurses and other medical staff have performed 5,000 transplants since 1984.
Wednesday, June 10, 2015
Tuesday, April 7, 2015